|
Volumn 244, Issue 2, 1997, Pages
|
The Riluzole Early Access Programme: Descriptive analysis of 844 patients in France
|
Author keywords
Amyotrophic lateral sclerosis; Clinical trials; Riluzole
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
AMINO ACID RECEPTOR BLOCKING AGENT;
RILUZOLE;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
AMYOTROPHIC LATERAL SCLEROSIS;
BREAST CANCER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CORONARY ARTERY DISEASE;
DEATH;
DIARRHEA;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
FRANCE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
OUTPATIENT;
PARESTHESIA;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RISK;
SURVIVAL;
TRACHEOSTOMY;
VOMITING;
AGED;
AMYOTROPHIC LATERAL SCLEROSIS;
FEMALE;
FRANCE;
HUMANS;
MALE;
MIDDLE AGED;
NEUROPROTECTIVE AGENTS;
RILUZOLE;
RISK;
SURVIVAL ANALYSIS;
THIAZOLES;
TIME FACTORS;
TRACHEOSTOMY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 0030960258
PISSN: 09391517
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (19)
|
References (2)
|